Ledger.Open graph →

SEC Form D · filed March 25, 2015

NGM BIOPHARMACEUTICALS INC

Offering

$106.0M

Sold

$106.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

William J. Rieflin · South San Francisco, CAExec · Director Mchenry T. Tichenor, Jr · Dallas, TXDirector Jin-Long Chen · South San Francisco, CAExec · Director David V. Schnell · Palo Alto, CADirector Mark V. Leschly · Palo Alto, CADirector Peter V. Svennilson · South San Francisco, CADirector David V. Goeddel · South San Francisco, CADirector James R. Wymer · Fairview Park, OHDirector Gail Naughton · Encinitas, CADirector Peter Rathjens · Grand Cayman, Cayman IslandsDirector Michael Hormaechea · Boise, IDDirector James J. Lynch · HARTFORD, CTExec · Director Steven J. Kapiloff · HARTFORD, CTExec · Director Monika Wingate · Madison, WIDirector Jane Boutelle · Madison, WIExec · Director Michael Phippen · Mill Valley, CAExec · Director Elliott Elbaz · Mill Valley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗